Lack of T cell proliferation without induction of nonresponsiveness after antigen presentation by endothelial cells

被引:20
作者
Marelli-Berg, FM
Frasca, L
Imani, N
Lombardi, G
Lechler, RI
机构
[1] Imperial Coll Sch Med, Dept Immunol, London W12 0NN, England
[2] Univ La Sapienza, Dept Biol Cellulare & Sviluppo, Rome, Italy
关键词
D O I
10.1097/00007890-199907270-00021
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background After priming or reactivation in lymph nodes, T cells recirculate to sites of inflammation, and enter tissues by migrating across activated endothelium. Given that activated endothelial and tissue parenchymal cells express both class I and class II MHC molecules, it is probable that transmigrating T cells encounter cognate antigen on endothelial cells, and on tissue parenchymal cells once they have entered the tissue. Methods. In this study the consequences of antigen presentation by endothelial and epithelial cells to human CD4(+) T cell clones were analyzed and compared by a two-step culture system. Results. T cell clones that required B7-mediated costimulation to be activated were found not to be able to proliferate to antigen presented by either endothelial or epithelial cells, unless trans-costimulation was provided by the addition of B7-transfected cells in the cultures. Furthermore, antigen presentation by epithelial cells induced nonresponsiveness in the T cell clones. In contrast, after cognate recognition on endothelial cells, the ability of the T cell clones to proliferate to a subsequent rechallenge with antigen presented on a specialized APC was unaffected. Conclusions. These data suggest that endothelial cells have unique properties as antigen-presenting cells, in that they do not influence the subsequent reactivity of cognate T cells.
引用
收藏
页码:280 / 287
页数:8
相关论文
共 33 条
[31]   MYOBLASTS FAIL TO STIMULATE T-CELLS BUT INDUCE TOLERANCE [J].
WARRENS, AN ;
ZHANG, JY ;
SIDHU, S ;
WATT, DJ ;
LOMBARDI, G ;
SEWRY, CA ;
LECHLER, RI .
INTERNATIONAL IMMUNOLOGY, 1994, 6 (06) :847-853
[32]  
WEETMAN AP, 1986, CLIN IMMUNOL IMMUNOP, V39, P131
[33]  
WILLIAMS ME, 1990, J IMMUNOL, V144, P1208